DE50009220D1 - Verwendung von moxonidin zur behandlung nach herzinfarkt - Google Patents

Verwendung von moxonidin zur behandlung nach herzinfarkt

Info

Publication number
DE50009220D1
DE50009220D1 DE50009220T DE50009220T DE50009220D1 DE 50009220 D1 DE50009220 D1 DE 50009220D1 DE 50009220 T DE50009220 T DE 50009220T DE 50009220 T DE50009220 T DE 50009220T DE 50009220 D1 DE50009220 D1 DE 50009220D1
Authority
DE
Germany
Prior art keywords
moxonidine
infarction
myocardial
physiologically compatible
myocardial infarction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50009220T
Other languages
German (de)
English (en)
Inventor
Gertruida Schoemaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Priority to DE50009220T priority Critical patent/DE50009220D1/de
Application granted granted Critical
Publication of DE50009220D1 publication Critical patent/DE50009220D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Details Of Spanners, Wrenches, And Screw Drivers And Accessories (AREA)
  • Heat Treatment Of Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DE50009220T 1999-02-01 2000-01-28 Verwendung von moxonidin zur behandlung nach herzinfarkt Expired - Lifetime DE50009220D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE50009220T DE50009220D1 (de) 1999-02-01 2000-01-28 Verwendung von moxonidin zur behandlung nach herzinfarkt

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19903780 1999-02-01
DE50009220T DE50009220D1 (de) 1999-02-01 2000-01-28 Verwendung von moxonidin zur behandlung nach herzinfarkt
PCT/EP2000/000655 WO2000045820A1 (de) 1999-02-01 2000-01-28 Verwendung von moxonidin zur behandlung nach herzinfarkt

Publications (1)

Publication Number Publication Date
DE50009220D1 true DE50009220D1 (de) 2005-02-17

Family

ID=7895940

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10003771A Withdrawn DE10003771A1 (de) 1999-02-01 2000-01-28 Arzneimittel zur Behandlung nach Herzinfarkt
DE50009220T Expired - Lifetime DE50009220D1 (de) 1999-02-01 2000-01-28 Verwendung von moxonidin zur behandlung nach herzinfarkt

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10003771A Withdrawn DE10003771A1 (de) 1999-02-01 2000-01-28 Arzneimittel zur Behandlung nach Herzinfarkt

Country Status (26)

Country Link
US (1) US7041303B2 (no)
EP (1) EP1150680B1 (no)
JP (1) JP4686027B2 (no)
KR (1) KR20010092793A (no)
CN (1) CN1166363C (no)
AT (1) ATE286731T1 (no)
AU (1) AU774855B2 (no)
BR (1) BR0007894A (no)
CA (1) CA2361600C (no)
CZ (1) CZ20012615A3 (no)
DE (2) DE10003771A1 (no)
DK (1) DK1150680T3 (no)
ES (1) ES2235829T3 (no)
HK (1) HK1042650B (no)
HU (1) HUP0105210A3 (no)
IL (1) IL144621A (no)
NO (1) NO321061B1 (no)
NZ (1) NZ513869A (no)
PL (1) PL195124B1 (no)
PT (1) PT1150680E (no)
RU (1) RU2261097C2 (no)
SK (1) SK10082001A3 (no)
TR (1) TR200102221T2 (no)
UA (1) UA67822C2 (no)
WO (1) WO2000045820A1 (no)
ZA (1) ZA200105827B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102850331B (zh) * 2012-09-17 2015-05-20 符爱清 一种化合物的制备方法
CN103483268B (zh) * 2013-09-17 2015-10-14 常州大学 一种4,6-二氯-2-甲基-5-硝基嘧啶的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
AU3233197A (en) * 1996-06-06 1998-01-05 Eli Lilly And Company Formulation and method for treating congestive heart failure

Also Published As

Publication number Publication date
KR20010092793A (ko) 2001-10-26
AU2440400A (en) 2000-08-25
HUP0105210A2 (hu) 2002-05-29
IL144621A (en) 2004-12-15
UA67822C2 (uk) 2004-07-15
ZA200105827B (en) 2002-07-16
IL144621A0 (en) 2002-05-23
NZ513869A (en) 2001-09-28
EP1150680B1 (de) 2005-01-12
ES2235829T3 (es) 2005-07-16
HK1042650A1 (en) 2002-08-23
WO2000045820A1 (de) 2000-08-10
PL350559A1 (en) 2002-12-16
NO321061B1 (no) 2006-03-06
JP2002536334A (ja) 2002-10-29
CN1338938A (zh) 2002-03-06
CA2361600A1 (en) 2000-08-10
DK1150680T3 (da) 2005-03-07
TR200102221T2 (tr) 2002-01-21
HK1042650B (zh) 2005-05-06
NO20013753L (no) 2001-09-28
DE10003771A1 (de) 2000-08-03
PT1150680E (pt) 2005-03-31
SK10082001A3 (sk) 2002-04-04
EP1150680A1 (de) 2001-11-07
RU2261097C2 (ru) 2005-09-27
US20020045633A1 (en) 2002-04-18
PL195124B1 (pl) 2007-08-31
AU774855B2 (en) 2004-07-08
CA2361600C (en) 2008-08-26
HUP0105210A3 (en) 2003-01-28
CN1166363C (zh) 2004-09-15
BR0007894A (pt) 2001-10-30
ATE286731T1 (de) 2005-01-15
JP4686027B2 (ja) 2011-05-18
CZ20012615A3 (cs) 2002-01-16
NO20013753D0 (no) 2001-07-31
US7041303B2 (en) 2006-05-09

Similar Documents

Publication Publication Date Title
BR0108452A (pt) Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
DE60137635D1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
HK1130422A1 (en) A new use of deferiprone
RU95106821A (ru) Циклопептиды, способ их получения, фармацевтическая композиция и способ ее получения
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
TR199701121T1 (xx) Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
WO2004006849A3 (en) Combinations of drugs for the treatment of neoplasms
DE50009220D1 (de) Verwendung von moxonidin zur behandlung nach herzinfarkt
DE69733557D1 (de) Endothelin-antagonisten zur behandlung von herzversagen
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DE60200160D1 (de) Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
ATE268173T1 (de) Methoden zur behandlung von neurombedingten schmerzen
ATE207353T1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
HUP9801894A2 (hu) Dofetilid alkalmazása kongesztív szívpanaszok kezelésére szolgáló gyógyszerkészítmények előállítására
NO20091111L (no) Anvendelse av R(+)-alfa-(2,3-dimetoksyfenyl)-l-[2-(4-fluorfenyl)etyl]-4-piperidin-metanol for behandling av sovnforstyrrelser
DE60121978D1 (de) 7-CHLOR-4-HYDROXY-2-(2-PYRIDYLETHYL)-1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON SCHMERZEN
ATE486594T1 (de) Methode zur behandlung von herzinsuffizienz
TH41860A (th) การใช้ขมิ้นชันหรือสารสกัดจากขมิ้นชันระงับและ/หรือรักษาโรคเก๊า และ/หรือลดกรดยูริคในเลือดในผู้ป่วยที่มีระดับกรดยูริคในเลือดสูง
ECSP992840A (es) Procedimiento para tratar la insuficiencia cardiaca

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1150680

Country of ref document: EP

Representative=s name: LUTZ WERNER BAURIEGEL, 30173 HANNOVER, DE